诺和诺德当地时间12月14日宣布,与诺和控股收购美国合同制药商Catalent的审查相关的所有监管成交条件均已满足,双方现在可以自由完成交易。诺和诺德预计收购将在未来几天内完成。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.